Athenex, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Financial Results and Provides Corporate Update

by NASDAQ Market News February 27, 2020

NASDAQ Market News
Click here to email author

MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By Technology, By Application, By Region And Segment Forecasts, 2020 – 2027

Ads